Pathophysiology of Acute Liver Failure.
Dong V, Nanchal R, Karvellas CJ.
Nutr Clin Pract. 2020 Feb;35(1):24-29. doi: 10.1002/ncp.10459. Epub 2019 Dec 15.
Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review.
Armenian P, Vo KT, Barr-Walker J, Lynch KL.
Neuropharmacology. 2018 May 15;134(Pt A):121-132. doi: 10.1016/j.neuropharm.2017.10.016. Epub 2017 Oct 14.
The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis.
Ciccarone D.
Curr Opin Psychiatry. 2021 Jul 1;34(4):344-350. doi: 10.1097/YCO.0000000000000717.
Naloxone.
Handal KA, Schauben JL, Salamone FR.
Ann Emerg Med. 1983 Jul;12(7):438-45. doi: 10.1016/s0196-0644(83)80343-6.
Designer drugs – still a threat?
Rozenek EB, Wilczyńska K, Górska M, Waszkiewicz N.
Przegl Epidemiol. 2019;73(3):337-347. doi: 10.32394/pe.73.23.
Blood concentrations of new synthetic opioids.
Adamowicz P, Nowak K.
Int J Legal Med. 2022 Jan;136(1):107-122. doi: 10.1007/s00414-021-02729-2. Epub 2021 Oct 22.
[Fentanyl tea].
Darling SS, Mærkedahl R.
Ugeskr Laeger. 2014 Feb 17;176(8A):V07130459.
Newly Emerging Drugs of Abuse.
Tamama K, Lynch MJ.
Handb Exp Pharmacol. 2020;258:463-502. doi: 10.1007/164_2019_260.
[New psychoactive substances in emergency medicine].
Marinowitz R, Strube J, Schaper A.
Nervenarzt. 2024 Jan;95(1):28-34. doi: 10.1007/s00115-023-01602-4. Epub 2024 Jan 8.
U-47700: A Clinical Review of the Literature.
Rambaran KA, Fleming SW, An J, Burkhart S, Furmaga J, Kleinschmidt KC, Spiekerman AM, Alzghari SK.
J Emerg Med. 2017 Oct;53(4):509-519. doi: 10.1016/j.jemermed.2017.05.034. Epub 2017 Sep 12.
